Patent ID: 9452126
Filing Date: 2016-09-27
CPC Classification: A61K,A61P,A61Q

Claim Text:
1. A pharmaceutical/cosmetic composition, wherein the composition comprises a dermatologically effective amount of at least one inhibitor of hyaluronic acid degradation, at least one hyaluronic acid oligomer, and at least one retinoid and/or salt and/or ester thereof, formulated into a physiologically acceptable medium, wherein the inhibitor of hyaluronic acid degradation is selected from the group consisting of glycyrrhizin, glycyrrhetinic acid, a salt of glycyrrhizin, and a salt of glycyrrhetinic acid, wherein the hyaluronic acid oligomer is selected from the group consisting of hyaluronic acid tetramer, hyaluronic acid pentamer, and hyaluronic acid hexamer, and wherein a concentration of the at least one inhibitor of hyaluronic acid degradation is 100 μM to 800 μM, a concentration of the at least one hyaluronic acid oligomer is 0.1 mg/ml to 2 mg/ml, and a concentration of the at least one retinoid and/or salt and/or ester thereof is 1 nM to 100 nM.